Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Monika Tomaszewska-Kiecana, Anna Dryja, Martin Ullmann, Corinne Petit-Frere, Andras Illes, Christos Dagres & Joëlle Monnet. (2023) Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Expert Review of Clinical Immunology 19:4, pages 447-455.
Read now
Read now
Monika Tomaszewska-Kiecana, Martin Ullmann, Corinne Petit-Frere, Joëlle Monnet, Christos Dagres & Andras Illes. (2023) Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults. Expert Review of Clinical Immunology 19:4, pages 439-446.
Read now
Read now
Farwa Jafri, Zachary L. Taylor, Daniel Gonzalez & Valentina Shakhnovich. (2023) Effects of obesity on the pharmacology of proton pump inhibitors: current understanding and future implications for patient care and research. Expert Opinion on Drug Metabolism & Toxicology 19:1, pages 1-11.
Read now
Read now
Tan Zhang, Elke H.J. Krekels, Cornelis Smit & Catherijne A.J. Knibbe. (2022) Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes. Expert Opinion on Drug Metabolism & Toxicology 18:10, pages 657-674.
Read now
Read now
Kaifeng Chen, Ping Luo, Guoping Yang, Shaihong Zhu, Chenhui Deng, Junjie Ding, Yaqi Lin, Liyong Zhu & Qi Pei. (2022) Population pharmacokinetics of omeprazole in obese and normal-weight adults. Expert Review of Clinical Pharmacology 15:4, pages 461-471.
Read now
Read now
Cornélie Fanton D’Andon, Patricia Correia, Josselin Rigaill, Benjamin Kably, Sophie Perinel-Ragey & Manon Launay. (2022) Ceftazidime dosing in obese patients: is it time for more?. Expert Opinion on Drug Metabolism & Toxicology 18:4, pages 277-284.
Read now
Read now
Articles from other publishers (93)
Tan Zhang, Cornelis Smit, Catherine M. T. Sherwin, Catherijne A. J. Knibbe & Elke H. J. Krekels. (2023) Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents. Clinical Pharmacokinetics 62:5, pages 749-759.
Crossref
Crossref
Luigi Barrea, Ludovica Verde, Luigi Schiavo, Gerardo Sarno, Elisabetta Camajani, Antonio Iannelli, Massimiliano Caprio, Vincenzo Pilone, Annamaria Colao & Giovanna Muscogiuri. (2023) Very Low-Calorie Ketogenic Diet (VLCKD) as Pre-Operative First-Line Dietary Therapy in Patients with Obesity Who Are Candidates for Bariatric Surgery. Nutrients 15:8, pages 1907.
Crossref
Crossref
Mahmoud E. Elrggal, Abdul Haseeb, Manal AlGethamy, Umar Ahsan, Zikria Saleem, Areej Sultan Althaqafi, Sattam Saad Alshuail, Zohair Ahmad Alsiddiqi, Muhammad Shahid Iqbal, Albaraa Faraj Alzahrani, Abdullmoin AlQarni, Rozan Mohammad Radwan, Ameer Khalid Saab Qul, Ahmad Jamal Mahrous, Jumana Majdi Alsharif, Mayyasah Khalid Alqurashi, Hani Saleh Faidah & Mohammed Aldurdunji. (2023) Dose optimization of vancomycin in obese patients: A systematic review. Frontiers in Pharmacology 14.
Crossref
Crossref
Zhicheng Guo, Meng Li, Jianguang Cai, Weiqi Gong, Yin Liu & Ze Liu. (2023) Effect of High-Intensity Interval Training vs. Moderate-Intensity Continuous Training on Fat Loss and Cardiorespiratory Fitness in the Young and Middle-Aged a Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 20:6, pages 4741.
Crossref
Crossref
João Pedro Thimotheo Batista, Lucas Alexandre Santos Marzano, Renata Aguiar Menezes Silva, Karla Emília de Sá Rodrigues & Ana Cristina Simões e Silva. (2023) Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative
Review. Current Medicinal Chemistry 30:9, pages 1003-1028.
Crossref
Crossref
Cyril Leven, Pauline Ménard, Isabelle Gouin-Thibault, Alice Ballerie, Karine Lacut, Edouard Ollier & Jérémie Théreaux. (2023) Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations. Pharmaceutics 15:2, pages 665.
Crossref
Crossref
Rosana G. Bianchettin, Carl J. Lavie & Francisco Lopez-Jimenez. (2023) Challenges in Cardiovascular Evaluation and Management of Obese Patients. Journal of the American College of Cardiology 81:5, pages 490-504.
Crossref
Crossref
Mattia Berton, Sara Bettonte, Felix Stader, Manuel Battegay & Catia Marzolini. (2022) Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals. Clinical Pharmacokinetics 62:2, pages 277-295.
Crossref
Crossref
Karima Begriche, Clémence Penhoat, Pénélope Bernabeu-Gentey, Julie Massart & Bernard Fromenty. (2023) Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review. Livers 3:1, pages 33-53.
Crossref
Crossref
Enkosi Mondleki, Clifford G. Banda, Nomathemba C. Chandiwana, Simiso Sokhela, Lubbe Wiesner, Francois Venter, Gary Maartens & Phumla Z. Sinxadi. (2022) Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV. Southern African Journal of HIV Medicine 23:1.
Crossref
Crossref
Majdoleen Alalawneh, Ahmed Awaisu & Ousama Rachid. (2022) Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review. Clinical Pharmacokinetics 61:12, pages 1677-1695.
Crossref
Crossref
Yuping Wang, Jie Zhu, Luchen Shan, Cunchuan Wang, Zhiyong Dong & Wah Yang. (2022) Drug-Related Problems in Bariatric Surgery: a Retrospective Study. Obesity Surgery 32:12, pages 3961-3972.
Crossref
Crossref
Anja Leppin & Jesper Bo Nielsen. (2022) Readiness to Accept Genetic Testing for Personalized Medicine: Survey Findings on the Role of Socio-Demographic Characteristics, Health Vulnerabilities, Perceived Genetic Risk and Personality Factors. Journal of Personalized Medicine 12:11, pages 1836.
Crossref
Crossref
Ugo INDRACCOLO, Alice POGGI, Maria G. LOMBANA MARINO, Beatrice BIANCHI, Silvia FANARO, Anna TAROCCO, Erica SANTI & Pantaleo GRECO. (2022) Maternal obesity and adverse respiratory outcomes in late preterm neonates. Gazzetta Medica Italiana Archivio per le Scienze Mediche 181:9.
Crossref
Crossref
Kine Eide Kvitne, Anders Åsberg, Line K. Johnson, Christine Wegler, Jens K. Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Rune Sandbu, Eva Skovlund, Hege Christensen, Rasmus Jansson‐Löfmark, Jøran Hjelmesæth & Ida Robertsen. (2022)
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome
P450
in patients with obesity
. Clinical and Translational Science 15:11, pages 2685-2696.
Crossref
Crossref
David J. Greenblatt, Christopher D. Bruno, Jerold S. Harmatz, Qingchen Zhang & Christina R. Chow. (2022) Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy. The Journal of Clinical Pharmacology 62:11, pages 1350-1363.
Crossref
Crossref
Lishi Lin, Marcel Soesan, Dorieke E. M. van Balen, Jos H. Beijnen & Alwin D. R. Huitema. (2022) The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer. Breast Cancer Research and Treatment 195:3, pages 325-331.
Crossref
Crossref
Janthima Methaneethorn, Rowan AlEjielat & Nattawut Leelakanok. (2022) Factors influencing methotrexate and methotrexate polyglutamate in patients with rheumatoid arthritis: a systematic review of population pharmacokinetics. Drug Metabolism and Personalized Therapy 37:3, pages 229-240.
Crossref
Crossref
A. Ram Doo, Min Jong Ki, Seong Ok Park, Jun Ho Lee & Seonghoon Ko. (2022) Influence of body fatness on propofol requirements for loss of consciousness in target-controlled infusion: A STROBE-compliant study. Medicine 101:35, pages e30179.
Crossref
Crossref
Kine Eide Kvitne, Veronica Krogstad, Christine Wegler, Line Kristin Johnson, Marianne K. Kringen, Markus Herberg Hovd, Jens K. Hertel, Maria Heijer, Rune Sandbu, Eva Skovlund, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Jøran Hjelmesæth, Anders Åsberg, Rasmus Jansson‐Löfmark, Hege Christensen & Ida Robertsen. (2022) Short‐ and long‐term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity. British Journal of Clinical Pharmacology 88:9, pages 4121-4133.
Crossref
Crossref
Toyosi Solanke, Festus Kamau, Tonya Esterhuizen, Gary Maartens, Saye Khoo, John A. Joska, Tracy Kellermann, Hans. Strijdom & Eric H. Decloedt. (2022) Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 91:1, pages 101-108.
Crossref
Crossref
Koen P. van Rhee, Cornelis Smit, Roeland E. Wasmann, Paul D. van der Linden, Rene Wiezer, Eric P. A. Van Dongen, Elke H. J. Krekels, Roger J. M. Brüggemann & Catherijne A. J. Knibbe. (2022) Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study. Clinical Pharmacokinetics 61:8, pages 1167-1175.
Crossref
Crossref
Jennifer Lynn Ford, Jacqueline G. Gerhart, Andrea N. Edginton, Jack A. Yanovski, Yuen Yi Hon & Daniel Gonzalez. (2022) Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity. The Journal of Clinical Pharmacology 62:8, pages 960-969.
Crossref
Crossref
Lu Chen, Koen P van Rhee, Roeland E Wasmann, Elke H J Krekels, Marinus J Wiezer, Eric P A van Dongen, Paul E Verweij, Paul D van der Linden, Roger J Brüggemann & Catherijne A J Knibbe. (2022) Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults. Journal of Antimicrobial Chemotherapy 77:8, pages 2217-2226.
Crossref
Crossref
Jinjin Zhao, Yaxin Fan, Minjie Yang, Xiaoyu Liang, Jufang Wu, Yuancheng Chen, Beining Guo, Huifang Zhang, Ruilan Wang, Fengying Zhang, Jingqing Hang, Huayin Li & Jing Zhang. (2022) Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study. Antibiotics 11:7, pages 837.
Crossref
Crossref
Ana Socorro Rodríguez‐Báez, Ana Patricia Huerta‐García, Susanna Edith Medellín‐Garibay, Cristian Jazmín Rodríguez‐Pinal, Marco Ulises Martínez‐Martínez, David Herrera‐Van Oostdam, Carlos Abud‐Mendoza, Silvia Romano‐Moreno & Rosa del Carmen Milán‐Segovia. (2022) Disease activity and therapeutic drug monitoring of polyglutamates of methotrexate after daily or weekly administration of low‐dose methotrexate in patients recently diagnosed with rheumatoid arthritis. Basic & Clinical Pharmacology & Toxicology 130:6, pages 644-654.
Crossref
Crossref
Hanadi H. Alrammaal, Khaled Abduljalil, Victoria Hodgetts Morton, R. Katie Morris, John F. Marriott, Hsu P. Chong & Hannah K. Batchelor. (2022) Application of a Physiologically Based Pharmacokinetic Model to Predict Cefazolin and Cefuroxime Disposition in Obese Pregnant Women Undergoing Caesarean Section. Pharmaceutics 14:6, pages 1162.
Crossref
Crossref
Chen Chaoyang, Dong Xiu, Wei Ran, Ma Lingyun, Zhao Simiao, Li Ruoming, Zhang Enyao, Zhou Ying, Cui Yimin & Liu Zhenming. (2022) Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients With Multiple Sclerosis: Analyses of Published Clinical Trials. Frontiers in Pharmacology 13.
Crossref
Crossref
Kath Williamson, David N. Blane & Michael E.J. Lean. (2022) Challenges in obtaining accurate anthropometric measures for adults with severe obesity: A community-based study. Scandinavian Journal of Public Health, pages 140349482210891.
Crossref
Crossref
Sarah Baklouti, Peggy Gandia & Didier Concordet. (2022) “De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring. Clinical Pharmacokinetics 61:5, pages 749-757.
Crossref
Crossref
Miyoung Lee, Jamie A. G. Hamilton, Ganesh R. Talekar, Anthony J. Ross, Langston Michael, Manali Rupji, Bhakti Dwivedi, Sunil S. Raikar, Jeremy Boss, Christopher D. Scharer, Douglas K. Graham, Deborah DeRyckere, Christopher C. Porter & Curtis J. Henry. (2022) Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. Nature Communications 13:1.
Crossref
Crossref
Vincent Martin, A. Jim Nagy, Marina Janelidze, Gvantsa Giorgadze, Joe Hirman, Roger Cady, Lahar Mehta & Dawn C. Buse. (2022) Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2. Clinical Therapeutics 44:3, pages 389-402.
Crossref
Crossref
Jacqueline G. Gerhart, Fernando O. Carreño, Andrea N. Edginton, Jaydeep Sinha, Eliana M. Perrin, Karan R. Kumar, Aruna Rikhi, Christoph P. Hornik, Vincent Harris, Samit Ganguly, Michael Cohen-Wolkowiez, Daniel Gonzalez, Daniel K. BenjaminJr.Jr., Christoph Hornik, Kanecia Zimmerman, Phyllis Kennel, Rose Beci, Chi Dang Hornik, Gregory L. Kearns, Matthew Laughon, Ian M. Paul, Janice Sullivan, Kelly Wade, Paula Delmore, Eunice Kennedy, Perdita Taylor-Zapata, June Lee, Ravinder Anand, Gaurav Sharma, Gina Simone, Kim Kaneshige, Lawrence Taylor, Ann Thomas Green & Robert H. Lurie. (2021) Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics 61:2, pages 307-320.
Crossref
Crossref
Julie Massart, Karima Begriche, Anne Corlu & Bernard Fromenty. (2022) Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease. International Journal of Molecular Sciences 23:3, pages 1062.
Crossref
Crossref
Merel van Nuland, Tessa F. Ververs & Marnix G. E. H. Lam. (2022) Dosing Therapeutic Radiopharmaceuticals in Obese Patients. International Journal of Molecular Sciences 23:2, pages 818.
Crossref
Crossref
Sterling Lee, Ashley Reid, Suhong Tong, Lori Silveira, James J. Thomas & Melissa M. Masaracchia. (2022) A Retrospective Review of Opioid Prescribing Practices for At-Risk Pediatric Populations Undergoing Ambulatory Surgery. The Journal of Pediatric Pharmacology and Therapeutics 27:1, pages 51-56.
Crossref
Crossref
Yen-Jung Chen, Ju-Ting Lu, Chun-Wei Huang, Wei-Hsin Wu, Kuei-Fang Lee, Hsin-Tzu Liu & Lawrence Shih-Hsin Wu. (2021) Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy. Pharmacogenetics and Genomics 32:1, pages 31-38.
Crossref
Crossref
Saurav Verma, Shalabh Arora, Ranjit Kumar Sahoo, Prabhjot Singh, Brusabhanu Nayak, KP Haresh, Chandan J Das, Shamim A Shamim, Seema Kaushal & Atul Batra. (2022) Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer - An exploratory analysis.. Cancer Treatment and Research Communications 31, pages 100520.
Crossref
Crossref
Cornelis Smit, Daniela Hofmann, Somphou Sayasone, Jennifer Keiser & Marc Pfister. (2021) Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen. Clinical Pharmacokinetics 61:1, pages 123-132.
Crossref
Crossref
Christoph G. Dietrich. 2022. Nicht-alkoholische Fettlebererkrankung. Nicht-alkoholische Fettlebererkrankung
311
322
.
Elissa Lin, Aaron Justin Yeoh & Violeta Popov. 2022. Nutrition, Weight, and Digestive Health. Nutrition, Weight, and Digestive Health
207
219
.
Christopher D. Bruno, Ahmed Elmokadem, Conrad Housand, Eric Burroughs Jordie, Christina R. Chow, Thomas P. Laughren & David J. Greenblatt. (2021) Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment. The Journal of Clinical Pharmacology 62:1, pages 55-65.
Crossref
Crossref
Kinga Czarnecka, Paulina Czarnecka, Olga Tronina, Teresa Bączkowska & Magdalena Durlik. (2021) Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. Immunity, Inflammation and Disease 10:1, pages 3-21.
Crossref
Crossref
Ida Di Giacinto, Martina Guarnera, Clelia Esposito, Stefano Falcetta, Gerardo Cortese, Giuseppe Pascarella, Massimiliano Sorbello & Rita Cataldo. (2021) Emergencies in obese patients: a narrative review. Journal of Anesthesia, Analgesia and Critical Care 1:1.
Crossref
Crossref
Sullivan A. Ayuso, Jordan N. Robinson, Paul D. Colavita & B. Todd Heniford. (2021) Smoking, Obesity, and the Elective Operation. Surgical Clinics of North America 101:6, pages 981-993.
Crossref
Crossref
Candice Falls & Sheila Melander. (2021) Obesity in the Critical Care Setting. Nursing Clinics of North America 56:4, pages 573-581.
Crossref
Crossref
Annemie Deiteren, Erwin Coenen, Sabine Lenders, Peter Verwilst, Erik Mannaert & Freya Rasschaert. (2021) Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes. Clinical and Translational Science 14:6, pages 2450-2460.
Crossref
Crossref
Sukirth M. Ganesan, Stephanie Vazana & Sandra Stuhr. (2021) Waistline to the gumline: Relationship between obesity and periodontal disease‐biological and management considerations. Periodontology 2000 87:1, pages 299-314.
Crossref
Crossref
Marie N. Celestin & Florin M. Musteata. (2021) Impact of Changes in Free Concentrations and Drug-Protein Binding on Drug Dosing Regimens in Special Populations and Disease States. Journal of Pharmaceutical Sciences 110:10, pages 3331-3344.
Crossref
Crossref
Helene Roy, Christel Bertoldi, Catherine Farrell & Elisabeth Rousseau. (2021) Prescribing drugs to overweight and obese children: Balancing efficacy and safety. Paediatrics & Child Health 26:6, pages e236-e239.
Crossref
Crossref
Ana Luiza P.P.d.P. Soares, Maiara C. Montanha, Conrado d.S. Alcantara, Sandra R.B. Silva, Cristina M. Kuroda, Sérgio S. Yamada, Antônio E. Nicacio, Liane Maldaner, Jesui V. Visentainer, Caroline F. Simões, João Carlos Locatelli, Wendell A. Lopes, Josmar Mazucheli, Andrea Diniz, Paulo J.P.A. Paixão & Elza Kimura. (2021) Pharmacokinetics of amoxicillin in obese and nonobese subjects. British Journal of Clinical Pharmacology 87:8, pages 3227-3233.
Crossref
Crossref
Christopher D. Bruno, Jerold S. Harmatz, Su X. Duan, Qingchen Zhang, Christina R. Chow & David J. Greenblatt. (2021) Effect of lipophilicity on drug distribution and elimination: Influence of obesity. British Journal of Clinical Pharmacology 87:8, pages 3197-3205.
Crossref
Crossref
Rima H. Bouajram & Linda Awdishu. (2021) A Clinician’s Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy. Kidney International Reports 6:8, pages 2033-2048.
Crossref
Crossref
Ana P. Huerta‐García, Ana S. Rodríguez‐Báez, Susanna E. Medellín‐Garibay, Diana P. Portales‐Pérez, Marco U. Martínez‐Martínez, Carlos Abud‐Mendoza, David Herrera‐Van Oostdam, Silvia Romano‐Moreno & Rosa del C. Milán‐Segovia. (2021) Methotrexate Triglutamate as a Determinant of Clinical Response in Mexican Patients With Rheumatoid Arthritis: Pharmacokinetics and Dose Recommendation. The Journal of Clinical Pharmacology 61:8, pages 1118-1130.
Crossref
Crossref
N. Silvestris, A. Argentiero, A. Natalicchio, S. D'Oronzo, G.D. Beretta, S. Acquati, V. Adinolfi, P. Di Bartolo, R. Danesi, A. Faggiano, P. Ferrari, M. Gallo, S. Gori, L. Morviducci, A. Russo, E. Tuveri, M.C. Zatelli, M. Montagnani & F. Giorgino. (2021) Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper. ESMO Open 6:3, pages 100153.
Crossref
Crossref
Cornelis Smit, Sebastiaan C. Goulooze, Roger J. M. Brüggemann, Catherine M. Sherwin & Catherijne A. J. Knibbe. (2021) Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1–18 Years. The AAPS Journal 23:3.
Crossref
Crossref
Manjunath P. Pai. (2021) Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity. Clinical Pharmacology & Therapeutics 109:4, pages 942-951.
Crossref
Crossref
Maxim Kuzin, Ekkehard Haen, Christoph Hiemke, Benjamin Bochon, Karolina Bochon, Gerhard Gründer, Michael Paulzen & Georgios Schoretsanitis. (2021) Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis. Journal of Psychopharmacology 35:3, pages 273-278.
Crossref
Crossref
Mohamed A. Yassin, Nancy Kassem & Rola Ghassoub. (2021) How I treat obesity and obesity related surgery in patients with chronic myeloid leukemia: An outcome of an ELN project. Clinical Case Reports 9:3, pages 1228-1234.
Crossref
Crossref
Bhitta Surapat, Somnuek Sungkanuparph, Suppachok Kirdlarp, Nantaporn Lekpittaya & Krittaya Chunnguleum. (2020) Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID‐19). Journal of Clinical Pharmacy and Therapeutics 46:1, pages 236-239.
Crossref
Crossref
Chad A. Bousman, Susanne A. Bengesser, Katherine J. Aitchison, Azmeraw T. Amare, Harald Aschauer, Bernhard T. Baune, Bahareh Behroozi Asl, Jeffrey R. Bishop, Margit Burmeister, Boris Chaumette, Li-Shiun Chen, Zachary A. Cordner, Jürgen Deckert, Franziska Degenhardt, Lynn E. DeLisi, Lasse Folkersen, James L. Kennedy, Teri E. Klein, Joseph L. McClay, Francis J. McMahon, Richard Musil, Nancy L. Saccone, Katrin Sangkuhl, Robert M. Stowe, Ene-Choo Tan, Arun K. Tiwari, Clement C. Zai, Gwyneth Zai, Jianping Zhang, Andrea Gaedigk & Daniel J Müller. (2020) Review and Consensus on Pharmacogenomic Testing in
Psychiatry. Pharmacopsychiatry 54:01, pages 5-17.
Crossref
Crossref
Veronica Krogstad, Alexandra Peric, Ida Robertsen, Marianne K. Kringen, Maria Vistnes, Jøran Hjelmesæth, Rune Sandbu, Line Kristin Johnson, Philip Carlo Angeles, Rasmus Jansson-Löfmark, Cecilia Karlsson, Shalini Andersson, Anders Åsberg, Tommy B. Andersson & Hege Christensen. (2021) Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes. Journal of Pharmaceutical Sciences 110:1, pages 432-437.
Crossref
Crossref
Farwa Munir, Fizza Maqbool, Shahzaib Naeem, Shaharbano, Mavra Riaz Atif, Asad Ur Rehman, Sarfraz Ahmed, Faheem Mustafa, Muhammad Hassan, Shehla Munir & Atif Amin Baig. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance
489
504
.
Janelle D. Vaughns & Evan P. Nadler. 2021. Anesthetic Management in Pediatric General Surgery. Anesthetic Management in Pediatric General Surgery
295
303
.
Maya Campara, Laura M. Lourenco, Jennifer I. Melaragno & Tiffany E. Kaiser. (2021) Implications for body weight extremes in solid organ transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:1, pages 44-58.
Crossref
Crossref
Tomefa E Asempa, Sergey Izmailyan, Kenneth Lawrence & David P Nicolau. (2020) Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials. Open Forum Infectious Diseases 7:12.
Crossref
Crossref
G Mellon, K Hammas, C Burdet, X Duval, C Carette, N El-Helali, L Massias, F Mentré, S Czernichow & A -C Crémieux. (2020) Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav. Journal of Antimicrobial Chemotherapy 75:12, pages 3611-3618.
Crossref
Crossref
Fan Zhang, Yingting Duan, Yuhui Wei, Jianping Zhang, Xiaohua Ma, Haiyan Tian, Xiaohui Wang, Abdulaziz Ahmed Abduladheem Saad, Boxia Li & Xinan Wu. (2020) The inhibition of hepatic Pxr-Oatp2 pathway mediating decreased hepatic uptake of rosuvastatin in rats with high-fat diet-induced obesity. Life Sciences 257, pages 118079.
Crossref
Crossref
Sama Anvari, Yung Lee, Megan Lam, Aristithes G. Doumouras & Dennis Hong. (2020) The Effect of Bariatric Surgery on Oral Antibiotic Absorption: a Systematic Review. Obesity Surgery 30:8, pages 2883-2892.
Crossref
Crossref
Luigi Barrea, Gabriella Pugliese, Giovanna Muscogiuri, Daniela Laudisio, Annamaria Colao & Silvia Savastano. (2020) New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists. Minerva Endocrinologica 45:2.
Crossref
Crossref
Cornelis Smit, Mariska Y. M. Peeters, John N. van den Anker & Catherijne A. J. Knibbe. (2020) Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties. Clinical Pharmacokinetics 59:6, pages 659-669.
Crossref
Crossref
Rachel J. Tyson, Christine C. Park, J. Robert Powell, J. Herbert Patterson, Daniel Weiner, Paul B. Watkins & Daniel Gonzalez. (2020) Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables. Frontiers in Pharmacology 11.
Crossref
Crossref
Roeland E Wasmann, Cornelis Smit, Marieke H van Donselaar, Eric P A van Dongen, René M J Wiezer, Paul E Verweij, David M Burger, Catherijne A J Knibbe & Roger J M Brüggemann. (2020) Implications for IV posaconazole dosing in the era of obesity. Journal of Antimicrobial Chemotherapy 75:4, pages 1006-1013.
Crossref
Crossref
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein & Anette Müllertz. (2020) Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 147, pages 105280.
Crossref
Crossref
Cornelis Smit, Roeland E. Wasmann, Sebastiaan C. Goulooze, Marinus J. Wiezer, Eric P.A. Dongen, Johan W. Mouton, Roger J.M. Brüggemann & Catherijne A.J. Knibbe. (2020) Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals. British Journal of Clinical Pharmacology 86:2, pages 303-317.
Crossref
Crossref
Oscar Miguel Oreste Laudanno, Oscar Miguel Oreste Laudanno, Gabriel Esteban Ahumarán, Pablo Gollo, Marina Khoury, Marcelo Thome & Patricia Mariel Gonzalez. (2020) Tailored Helicobacter Pylori eradication therapy in obese patients undergoing bariatric surgery. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Marcus May, Christoph Schindler & Stefan Engeli. (2020) Modern pharmacological treatment of obese patients. Therapeutic Advances in Endocrinology and Metabolism 11, pages 204201881989752.
Crossref
Crossref
Manou Manpreet Kaur & Thomas Ind. 2020. Obesity and Gynecology. Obesity and Gynecology
223
243
.
Kenneth T. Moore. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
723
747
.
Jose Rodríguez-Morató, Albert Goday, Klaus Langohr, Mitona Pujadas, Ester Civit, Clara Pérez-Mañá, Esther Papaseit, Jose Manuel Ramon, David Benaiges, Olga Castañer, Magí Farré & Rafael de la Torre. (2019) Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity. Scientific Reports 9:1.
Crossref
Crossref
Frank C. Albers, Alberto Papi, Camille Taillé, Daniel J. Bratton, Eric S. Bradford, Steven W. Yancey & Namhee Kwon. (2019) Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA. Respiratory Research 20:1.
Crossref
Crossref
Chenxiao Tang & Samuel M. Poloyac. (2019) A Modeling-Based Approach to Estimate Fentanyl Pharmacokinetics in Obese Critically Ill Children*. Pediatric Critical Care Medicine 20:12, pages 1208-1209.
Crossref
Crossref
Cornelis Smit, Roeland E. Wasmann, Sebastiaan C. Goulooze, Eric J. Hazebroek, Eric P. A. Van Dongen, Desiree M. T. Burgers, Johan W. Mouton, Roger J. M. Brüggemann & Catherijne A. J. Knibbe. (2019) A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients. Clinical Pharmacokinetics 58:10, pages 1333-1343.
Crossref
Crossref
Jérémie Delaleu, Alexandre Destere, Lorry Hachon, Xavier Declèves & Célia Lloret-Linares. (2019) Glucocorticoids dosing in obese subjects: A systematic review. Therapies 74:4, pages 451-458.
Crossref
Crossref
Cornelis Smit, Roeland E. Wasmann, Marinus J. Wiezer, Hendricus P. A. van Dongen, Johan W. Mouton, Roger J. M. Brüggemann & Catherijne A. J. Knibbe. (2019) Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study. Pharmaceutical Research 36:8.
Crossref
Crossref
Christina Stolzenburg Oxlund, Manan Pareek, Benjamin Schnack Brandt Rasmussen, Muthiah Vaduganathan, Tor Biering-Sørensen, Christina Byrne, Zaid Almarzooq, Michael Hecht Olsen & Deepak L. Bhatt. (2019) Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial. The American Journal of Medicine 132:7, pages 840-846.
Crossref
Crossref
Giovanna Petrucci, Francesco Zaccardi, Alberto Giaretta, Viviana Cavalca, Esmeralda Capristo, Carmine Cardillo, Dario Pitocco, Benedetta Porro, Francesca Schinzari, Gianna Toffolo, Elena Tremoli & Bianca Rocca. (2019) Obesity is associated with impaired responsiveness to once‐daily low‐dose aspirin and in vivo platelet activation. Journal of Thrombosis and Haemostasis 17:6, pages 885-895.
Crossref
Crossref
Katherine H. Ross, Keerthi Gogineni, Preeti D. Subhedar, Jolinta Y. Lin & Lauren E. McCullough. (2019) Obesity and cancer treatment efficacy: Existing challenges and opportunities. Cancer 125:10, pages 1588-1592.
Crossref
Crossref
Sabine Kreilinger & Eljim P. Tesoro. 2019. Textbook of Neuroanesthesia and Neurocritical Care. Textbook of Neuroanesthesia and Neurocritical Care
33
39
.
Kenneth T. Moore. 2019. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
25
.
Ali Abdussalam, Marwa Al-Agili, Hamdah M. Al Nebaihi, Patrick R. Mayo, Raniah Q. Gabr & Dion R. Brocks. (2018) Dietary-Induced Obesity and Changes in the Biodistribution and Metabolism of Amiodarone in the Rat. Journal of Pharmaceutical Sciences 107:11, pages 2938-2945.
Crossref
Crossref
Renger F. Witkamp & Klaske van Norren. (2018) Let thy food be thy medicine….when possible. European Journal of Pharmacology 836, pages 102-114.
Crossref
Crossref
Guangpeng Zhou, Pinq Wang, Sen Lu, Chenchen Wang, Zuoling Xie, Wuyou Cao, Jijing Shi, Wenwen Zhu, Rui Wang, Guangpeng Zhou, Shaohua Wang & Pin Wang. (2021) Association Between BMI and Cardiovascular Benefits After More Intensive LDL-C Lowering Strategy: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref
Crossref